Existing user? Sign in
Share your needs with us, get contacted by law firms.
Free. Takes 2 min.
Drugs and medical devices are regulated in the United Kingdom by a dual framework. Medicines are overseen by the Medicines and Healthcare products Regulatory Agency (MHRA) under national legislation and European-inspired rules adapted post Brexit. Medical devices also fall under MHRA oversight, with specific regulations for the safe design, manufacture and post-market surveillance of devices sold in Great Britain and Northern Ireland.
The regulatory system covers product development, licensing, advertising, clinical trials, and post-market actions such as recalls and penalties. Practitioners, manufacturers, distributors and healthcare providers must comply with these rules to avoid enforcement action. In London and across England, Scotland and Wales, regulators enforce similar standards, with some jurisdiction-specific nuances for NI alignment with the EU framework.
"The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the United Kingdom."
For reliable guidance on regulatory requirements, consult official sources such as the MHRA and the UK government. These agencies publish licensing criteria, post-market obligations, adverse event reporting, and compliance resources that apply to London residents and businesses operating in the UK drug and device sectors.
Regulatory compliance is complex and failure to meet requirements can trigger penalties or recalls. A solicitor or regulatory attorney can help you navigate licensing, advertising, and post-market obligations.
The UK framework comprises several core statutes and regulations that shape how drugs and medical devices are developed, approved, marketed and monitored. Key provisions include the following laws and regulations:
Recent developments to watch include the UK’s transition to UK CA marking for most GB market devices, and post-Brexit regulatory adjustments that affect device conformity assessment and cross-border supply. For precise requirements and timelines, refer to official guidance.
"The UK Conformity Assessment (UKCA) marking is the new UK-wide marking for most goods to be sold in Great Britain, replacing the CE mark in many cases."
London businesses and individuals should monitor MHRA updates and gov.uk guidance to stay compliant with evolving regulatory expectations. Official resources provide the current scope of approvals, conformity assessment, and post-market obligations for medicines and devices.
The MHRA is the UK regulator for medicines and medical devices. It oversees licensing, post-market surveillance, adverse event reporting, and compliance enforcement across Great Britain and Northern Ireland.
Applications go to MHRA through established regulatory routes, with supporting data on safety, quality and efficacy. A solicitor can help assemble the dossier, coordinate ethics approvals, and liaise with regulators.
UKCA marking is the UK-wide conformity mark for GB markets. It became the default for most devices from January 2023, with transitional arrangements and NI considerations where relevant.
Approval timelines vary by product type and data quality, but routine non-clinical and clinical data reviews can take several months. A regulatory attorney helps manage timelines and prepare submissions efficiently.
Yes. An attorney can interpret notices, negotiate deadlines, and guide you through voluntary recall or corrective action processes to minimize penalties and disruption.
Costs depend on device complexity, data requirements, and market strategy. Typical expenses include testing, certification, application fees, and ongoing post-market surveillance obligations.
Trials require ethics approval, MHRA authorization, and detailed trial documentation. A lawyer helps align contracts, consent forms, and reporting obligations with regulatory standards.
CE is the EU conformity sign. UKCA is the UK marking used in Great Britain post Brexit, with specific guidance for NI markets that may still rely on CE or UKNI under certain conditions.
Yes, but you must meet UK regulatory requirements, including conformity assessment and UKCA marking where applicable. A local lawyer can navigate cross-border regulatory processes.
Regulators issue recall or safety action notices, and responsible parties must implement corrective actions promptly. Legal counsel helps coordinate communications, timelines and remediation plans.
Most devices require conformity assessment and post-market surveillance reporting. Some devices may require registration or notification with MHRA depending on the class and use.
Report to MHRA immediately and follow regulatory guidance. A lawyer can assist with investigation, enforcement cooperation, and risk mitigation for supply chain partners.
Lawzana helps you find the best lawyers and law firms in London through a curated and pre-screened list of qualified legal professionals. Our platform offers rankings and detailed profiles of attorneys and law firms, allowing you to compare based on practice areas, including Drugs & Medical Devices, experience, and client feedback.
Each profile includes a description of the firm's areas of practice, client reviews, team members and partners, year of establishment, spoken languages, office locations, contact information, social media presence, and any published articles or resources. Most firms on our platform speak English and are experienced in both local and international legal matters.
Get a quote from top-rated law firms in London, United States — quickly, securely, and without unnecessary hassle.
Disclaimer:
The information provided on this page is for general informational purposes only and does not constitute legal advice. While we strive to ensure the accuracy and relevance of the content, legal information may change over time, and interpretations of the law can vary. You should always consult with a qualified legal professional for advice specific to your situation.
We disclaim all liability for actions taken or not taken based on the content of this page. If you believe any information is incorrect or outdated, please contact us, and we will review and update it where appropriate.
